{"id":5630,"date":"2024-09-26T19:45:54","date_gmt":"2024-09-26T19:45:54","guid":{"rendered":"https:\/\/www.roctavian.com\/en-us\/?page_id=5630"},"modified":"2024-10-16T10:25:35","modified_gmt":"2024-10-16T10:25:35","slug":"am-i-eligible","status":"publish","type":"page","link":"https:\/\/www.roctavian.com\/en-us\/am-i-eligible\/","title":{"rendered":"AM I ELIGIBLE"},"content":{"rendered":"
\n\t
<\/div>\n\t
<\/div>\n\t
<\/div>\n\n\t
\n\t\t
\n\t\t\t\t\t\t \"\" \t\t<\/div>\t\t\n
\n
\n
\n

*Andrew W. was dosed with ROCTAVIAN in 2018 as a clinical study participant.<\/p>\n <\/div>\n <\/div>\n <\/div>\n \t<\/div>\n

\n
\n
\n

Andrew W., dad, husband, runner, and member of the hemophilia A community*<\/p>\n <\/div>\n <\/div>\n <\/div>\n\t<\/div>\n